Esterified Estrogens And Methyltestosterone Tablet
Product Images NDC 63629-9178

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Esterified Estrogens And Methyltestosterone (NDC 63629-9178). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ab03b87f-figure-01 (Esterified Estrogens And Methyltestosterone Tablet 1)

FDA Label Image

Ab03b87f-figure-02 (Esterified Estrogens And Methyltestosterone Tablet 2)

This table provides data on the relative and absolute risk observed in a study of women taking CE/MPA compared to a placebo group. The study observed events such as coronary heart disease, stroke, breast cancer, pulmonary embolism, and osteoporotic fractures, among others. The table displays the relative risk of each event in the CE/MPA group versus the placebo group, along with the absolute risk per 10,000 women-years. The confidence interval for each relative risk is also provided.*

FDA Label Image

Label (Lbl636299178)

This appears to be the description for a medication called "Esterified Estrogens and Methyltestosterone Tablets" that comes in a 100 tablet bottle. Each tablet contains 0.625mg of Esterified Estrogens and 1.25mg of Methyltestosterone. The dosage information should be found in the package insert. The medication should be stored at 20-25°C and out of the reach of children. The medication appears to be for prescription use only. A patient information leaflet should be included with each package that is dispensed.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.